Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

104 results about "Ischemic necrosis" patented technology

Regulation of transforming growth factor-beta (TGF-beta) gene expression in living cells via the application of specific and selective electric and electromagnetic fields

Methods and devices are described for the regulation of Transforming Growth actor (TGF)-β1, β2, and / or β3 protein gene expression in bone cells and other tissues via the capacitive coupling or inductive coupling of specific and selective electric fields to the bone cells or other tissues, where the specific and selective electric fields are generated by application of specific and selective electric and electromagnetic signals to electrodes or one or more coils or other field generating device disposed with respect to the bone cells or other tissues so as to facilitate the treatment of diseased or injured bone and other tissues. By gene expression is meant the up-regulation or down-regulation of the process whereby specific portions (genes) of the human genome (DNA) are transcribed into mRNA and subsequently translated into protein. Methods and devices are provided for the targeted treatment of injured or diseased bone and other tissue that include generating specific and selective electric and electromagnetic signals that generate fields in the target tissue optimized for increase of TGF-β1, β2, and / or β3 protein gene expression and exposing bone and other tissue to the fields generated by specific and selective signals so as to regulate TGF-β1, β2, and / or β3 protein gene expression in such tissue. The resulting methods and devices are useful for the targeted treatment of bone fractures, fractures at risk, delayed unions, nonunion of fractures, bone defects, spine fusions, osteonecrosis or avascular necrosis, as an adjunct to other therapies in the treatment of one or all of the above, in the treatment of osteoporosis, and in other conditions in which TGF-β1, β2, and / or β3 protein may be implicated.
Owner:THE TRUSTEES OF THE UNIV OF PENNSYLVANIA

Chinese medicine composition for treating ischemic necrosis of femoral head

The invention relates to a Chinese medicine composition for treating ischemic necrosis of femoral head, which solves the problems that the western medicine only releases pain, the Chinese medicine has long treatment period and slow effect, and the operation treatment has large risk and high cost as well as easy recrudescence. The Chinese medicine composition is prepared by the following raw materials according to the weight proportion: 10-100g of angelica, 20-50g of corydalis tuber, 20-60g of heracleum hemsleyanum michaux, 20-40g of frankincense, 20-40g of myrrh, 10-50g of angelica dahurica, 20-50g of cinnamon, 30-100g of rhizoma drynariae, 20-60g of radix dipsaci from Sichuan of China, 20-50g of rhizoma cibotii, 40-100g of lopseed, 20-50g of dragon's blood and 10-50g of eupolyphage sece steleophaga. The Chinese medicine composition has short treatment period and rapid effect, can eliminate the ischemic necrosis of femoral head and the inflammatory pain of rachitis, can eliminate mechanical pain of cervical vertebra and lumbar intervertebral disc protrusion, can repair fiber ring scission, builds the health, improves the microcirculation without side and toxic effects, and promotes the sequestrum absorption of the ischemic necrosis of femoral head and the regeneration of the bone trabecula, thereby achieving the purpose of addressing both the symptoms and root causes.
Owner:徐国厚

Urethra catheter for expansion of urethral canal and manufacturing method thereof

The invention discloses a urethra catheter for expansion of a urethral canal and a manufacturing method thereof. The manufacturing method comprises the following steps of; (1) preparing a urethra catheter; (2) preparing a positioning device; and (3) preparing an expansion device. The invention also discloses a produced manufactured in the above method. The method is simple and can be realized easily, and the cost is low. The urethra catheter has a delicate design and reasonable structure. After the urethra catheter inserted into the urethral canal, the positioning device and the expansion device in a narrow state can be tightly attached to the outer wall of the urethra catheter, the outside diameter of the urethra catheter can be reduced effectively, and pains of patients can be eased; the urethra catheter can be effectively positioned in the bladder by the positioning device to facilitate positioning and expansion operations of the expansion device for a part to be expanded, an intermittent inflation or liquid filling method is adopted during expansion, the urethral canal can be expanded, urethral stricture can be treated, mucosal ischemic necrosis can be avoided, the surgical safety and effectiveness can be improved greatly, and the large-scale promotion and application can be facilitated.
Owner:柳晓杰

Pressurized hollow nail

The invention relates to a medical appliance, in particular to a pressurized hollow nail, which comprises a hollow nail body, wherein a self-tapping blade head is arranged at an initial end of the nail body; the outer surface of an initial section and the outer surface of an end section of the nail body are both provided with threads; the thread pitch of the threads arranged on the outer surface of the end section is less than that of the threads arranged on the outer surface of the initial section; and the side wall of an intermediate section of the nail body is provided with a plurality of through holes. In the process of treating femur neck fracture with the hollow nail, as the hollow nail is provided with a plurality of through holes at both ends of a fracture line respectively, blood in spongy bones at a far end of the fracture line can be driven to enter into the hollow nail body through the through holes and flow out from through holes at a near end of the fracture line, and to be sent into a femoral head at the near end of the fracture line, thereby the blood exchange and circulation between two ends of a fracture section are realized and greatly accelerated. Moreover, the blood supply of corresponding femoral heads can be increased, and the fracture healing is promoted, thus the ischemic necrosis of the femoral heads is avoided. Therefore, the pressurized hollow nail is of great significance in the prevention of the ischemic necrosis of the femoral heads caused by the femur neck fracture.
Owner:洪宁

Detection method of adenovirus-mediated gene transfection autologous bone marrow mesenchymal stem cells

The invention discloses a detection method of adenovirus-mediated gene transfection autologous bone marrow mesenchymal stem cells. The detection method includes: using hBMP-2 genes to transfect bone marrow mesenchymal stem cells BMSCs by the aid of a recombinant defective adenovirus expression carrier Ad-hBMP-2, compositing the transfected cells with a allogeneic decalcified bone DBM stent material in an in-vitro manner, implanting into an ANFH animal model, and performing X-ray detection, transmission electron microscope detection, histological detection, immunohistochemical analysis (semiquantitative) and mechanical performance detection on the repaired femoral head. By the detection method, the conditions and influence factors of the proliferation, directional differentiation and degeneration of the stem cells are illustrated, cytology theoretical support is provided for methods using the stem cells to treat ANFH, and basis and support are provided for the clinical application of the methods using the stem cells to treat the ischemic necrosis of the femoral head by successfully demonstrating the relation between the number, differentiation, degeneration and the like of the bone marrow mesenchymal stem cells and the ischemic necrosis of the femoral head.
Owner:GUILIN MEDICAL UNIVERSITY

Chinese herbal medicine preparation used for treating avascular necrosis of femoral head

The invention discloses a Chinese herbal medicine preparation used for treating avascular necrosis of femoral head. The preparation is prepared from 10-15 parts of ligusticum, 3-9 parts of incised notopterygium rhizome and root, 10-25 parts of dragon's blood, 2-3 parts of common monkshood mother-root, 6-10 parts of Chinese quince, 6-12 parts of angelica dahurica, 5-10 parts of weeping forsythia fruit, 5-10 parts of fourstamen stephania root, 3-6 parts of safflower, 5-10 parts of drynaria, 6-10 parts of radix dipsaci, 3-5 parts of bamboo-living shiraia stroma, 2-3 parts of catechu, 4-8 parts of native copper, 2-6 parts of myrrh, 5-10 parts of frankincense, 3-6 parts of achyranthes bidentata, 5-10 parts of Chinese ephedra herb, 2-3 parts of kusnezoff monkshood mother-root, 5-10 parts of cucumber seed, 3-6 parts of rheum, 2-4 parts of saposhnikovia divaricata, 1-3 parts of borneol, 6-12 parts of lumbricus, 2-4 parts of heterophyllous wingseedtree root or stem, 2-4 parts of justicia procumbens, 4-6 parts of giantleaf ardisia rhizome, and 3-9 parts of gynura rhizome. The Chinese herbal medicines are decocted into a thick solution. The solution is filtered, recovered, bottled, sterilized, and preserved for later use. The Chinese herbal medicine preparation provided by the invention is advantaged in simple production technology, easy operation, convenient application, safe administration, and no toxic or side-effect.
Owner:邓华伦

Traditional Chinese medicine for treating ischemic necrosis of femoral head

The invention relates to the technical field of traditional Chinese medicines, and in particular relates to a traditional Chinese medicine for treating ischemic necrosis of femoral head. The traditional Chinese medicine for treating ischemic necrosis of femoral head is prepared from the following raw materials: cornu cervi, herba cistanche, resina draconis, frankincense, myrrh, salviae miltiorrhizae, flowers carthami, radix achyranthis bidentatae, eucommia ulmoides, woodwardia japonica, drynaria rhizome, schisandra chinensis, astragalus membranaceus, Chinese yam, angelica sinensis, radix rehmanniae preparata, costustoot, poria cocos, loranthus parasiticus, liquorice, notopterygium, radix clematidis, buddleja asiatica, ligularia japonica, cuneate lespedeza herb with root, common calanthe herb and herba inulae. According to the traditional Chinese medicine, the adopted medicinal materials are in supplement with each other; the traditional Chinese medicine is prepared by the theoretical composition of the traditional Chinese medicine according to a certain weight ratio, has a significant curative effect on treatment of ischemic necrosis of femoral head, and is abundant in raw material source, moderate in price, simple in process and easy to accept by patients; the pain of aches and limitation of motion of patients can be relieved or even avoided; the diseases are treated; the constitution of patients can be enhanced; and health is promoted.
Owner:陈亚娟

Degradable gel microspheres interposed in bronchus and application thereof

InactiveCN101912366ALung collapse does not occurNo pulmonary edemaAntibacterial agentsSurgerySide effectMicrosphere
The invention relates to degradable gel microspheres interposed in a bronchus and application thereof. The degradable gel microspheres comprise hyaluronic acid-calcium alginate gel microspheres and medicament-loaded chitosan-calcium alginate gel microspheres, wherein the hyaluronic acid-calcium alginate gel microspheres and the medicament-loaded chitosan-calcium alginate gel microspheres are mixed together uniformly according to proportion, and the volume ratio is 2:1-9. The degradable gel microspheres can be used for preparing sustained-release and controlled-release medicaments for treatinglung cancer, lung tumor, tuberculosis, pneumonia and bronchitis and a tissue engineering scaffold material. The degradable gel microspheres interposed in the bronchus do not block up a lung bronchus and also do not initiate ischemic necrosis of surrounding tissues of the bronchus, so the degradable gel microspheres can be used as the tissue engineering scaffold material and a medicament sustained-release scaffold. Two types of microspheres with different functions have complementary advantages, overcome the technical difficulties of microsphere blockage and pulmonary ventilation in the bronchus, and can significantly reduce toxic or side effect of medicaments and improve therapeutic indexes of the medicaments.
Owner:THE 309TH HOSPITAL OF CHINESE PEOPLES LIBERATION ARMY

Medicament for treating femoral head necrosis and preparation method thereof

The invention provides a medicament for treating femoral head necrosis. The medicament is prepared from the following traditional Chinese medicinal materials in parts by weight: 40-50 parts of pseudo-ginseng, 75-90 parts of suberect spatholobus stem, 75-90 parts of radix achyranthis bidentatae, 75-90 parts of medlar, 75-90 parts of teasel root, 75-90 parts of rhizoma drynariae (sand heated), 75-90 parts of salviae miltiorrhizae, 75-90 parts of Chinese angelica, 75-90 parts of ligusticum wallichii, 75-90 parts of cortex acanthopanacis, 115-130 parts of prepared rehmannia root, 115-130 parts of codonopsis pilosula, 75-90 parts of rhizoma atractylodis macrocephalae, 115-130 parts of prepared frankincense, 115-130 parts of prepared myrrh, 115-130 parts of corydalis tuber, 20-25 parts of rheum officinale, 75-90 parts of radix curcumae and 75-90 parts of costusroot. The medicament can be used for improving the testosterone of a rat caused by hydrocortisone, reducing T3 and T4, increasing the relative volume and average bone trabecula width, improving resistance of a kidney-deficiency mouse, improving relative bone volume reduction and average bone trabecula width reduction caused by tretinoin, improving contents of bone calcium and phosphor, improving microcirculation disturbance, diminishing swelling and relieving pain and improving immunity, and has a good curative effect in the aspect of treating femoral head necrosis.
Owner:郭永昌
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products